What in the world is going with the Barclays iPath Series B S&P 500 VIX Short-Term Futures (BATS:VXX) exchange-traded note (ETN)? Shares of the VXX ETN are up over 9% today at the time of writing and ...

The average one-year price target for iPath Series B S&P 500 VIX Short-Term Futures ETN (BATS:VXX) has been revised to $33.18 ...

Fintel reports that on December 2, 2025, JP Morgan Cazenove reiterated coverage of iPath Series B S&P 500 VIX Short-Term ...

Just like the Stelvio Pass Road in the Alps, the stock market doesn't move in a straight line. Be careful if you try to profit from the volatility, though. Image source: Pixabay You may know that the ...

VIX has surged to record levels this year, but historical analysis suggests that the downside is more likely from here. Roll yield will continue to take a toll on the returns of VXX, meaning that a ...

The iPath Series B S&P 500 VIX Short-Term Futures ETN is an inefficient hedge against market volatility due to concerns involving tracking error, negative roll yield, and timing difficulties.

The iPath S&P 500 Short-Term Futures ETN (VXX) is on pace for its biggest one-day percentage gain on record In fact, according to Schaeffer's Senior Quantitative Analyst Rocky White, this is the third ...

The following is a reprint of the market commentary from the April 2018 edition of The Option Advisor, published on March 23. For more information, or to subscribe to The Option Advisor -- featuring ...

The VXX ETN can be a great wealth-shrinker, especially if you don't understand it very well. Think twice before buying into the VXX ETN, though, as it can be a terrible investment. Let's go over why.

There are lots of misconceptions about the volatility-index-based VXX. Don't fall victim to any of them. It's not an ETF Many people assume the VXX is an ETF, an exchange-traded fund, but it's not.